Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Advicenne SA (ALDVI) Stock Price & Analysis

0 Followers

ALDVI Stock Chart & Stats

€0.65€0.01(3.81%)
At close: 5:30 PM GMT+1
€1€1.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 0.64 - EUR 0.67
52-Week Range
EUR 0.61 - EUR 2.35
Previous Close
EUR 0.63
Volume
N/A
Average Volume (3M)
25.52K
Market Cap
EUR 9.52M
Enterprise Value
EUR 38.08M
Total Cash (Recent Filing)
EUR 1.55M
Total Debt (Recent Filing)
EUR 21.18M
Price to Earnings (P/E)
219.5
Beta
0.62
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rare-disease Specialization

Specialization in rare kidney diseases gives Advicenne a clearly defined therapeutic focus and may support expertise in addressing chronic, underserved conditions. This positioning can help concentrate development and commercialization resources around targeted patient populations over the next several quarters.

Patient-adherence-oriented Formulations

Formulations aimed at improving dosing convenience and adherence address an important practical challenge in chronic treatment. If these attributes support continued prescription use, they could strengthen product utility and help differentiate Advicenne’s medicines within its focused therapeutic areas.

Improving Gross Profitability

The move to positive gross margin in 2025 indicates that product-level economics improved compared with the prior two years. Although this has not yet produced overall profitability, better gross profitability could provide a stronger foundation for operating leverage if revenue becomes more consistent.

Bears Say

Negative Equity And Fragile Capital Structure

Negative equity across four reported years signals a materially stressed capital structure and reduces financial flexibility. Sizable debt relative to the asset base may constrain investment choices and leave the company less able to absorb operating setbacks or fund expansion internally.

Persistent Cash Burn

Repeated negative operating and free cash flow shows that the business has not yet generated enough cash from operations to sustain itself. The renewed deterioration in 2025 increases reliance on external funding and can limit the resources available for development and commercialization.

Unprofitable And Volatile Revenue Base

A small, volatile revenue base combined with persistent operating losses and deeply negative net margins indicates that commercial activity has not yet translated into a sustainable earnings model. Negative growth in 2025 makes fixed-cost absorption and a timely path to profitability more difficult.

Advicenne SA News

ALDVI FAQ

What was Advicenne SA’s price range in the past 12 months?
Advicenne SA lowest stock price was €0.61 and its highest was €2.35 in the past 12 months.
What is Advicenne SA’s market cap?
Advicenne SA’s market cap is €9.52M.
When is Advicenne SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Advicenne SA’s earnings last quarter?
Advicenne SA released its earnings results on Sep 17, 2026. The company reported €0.32 earnings per share for the quarter.
Is Advicenne SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Advicenne SA pay dividends?
Advicenne SA does not currently pay dividends.
What is Advicenne SA’s EPS estimate?
Advicenne SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advicenne SA have?
Advicenne SA has 14,609,619 shares outstanding.
What happened to Advicenne SA’s price movement after its last earnings report?
Advicenne SA reported an EPS of €0.32 in its last earnings report. Following the earnings report the stock price went up 10.13%.
Which hedge fund is a major shareholder of Advicenne SA?
Currently, no hedge funds are holding shares in FR:ALDVI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology